Balance of Proliferation and Death
A key characteristic of any neoplasm is autonomous growth. However, the rapid increase in tissue mass occurs not only because cells begin to divide too quickly, but because tumor mass accumulation results from a combination of several factors. On one hand, the fraction of actively dividing cells increases sharply. On the other hand, a critical imbalance arises between proliferation and apoptosis.
Enhanced proliferation is usually the consequence of activating specific oncogenes or, conversely, inactivating tumor suppressor genes. At the same time, reduced cell death is directly linked to mutations in genomic regions that normally regulate cell death. This combination of factors, along with incomplete apoptosis, allows the tumor to grow relentlessly in size.
Apoptosis as an Antitumor Barrier
In a healthy organism, apoptosis serves as a powerful physiological barrier. It is an adequate tissue response to various pathological conditions, preventing the very development of malignant tumors.
This defense mechanism is logically straightforward: if a cell sustains severe genomic damage, it must undergo self-destruction. This scenario reliably blocks the transmission and accumulation of mutations to subsequent generations of daughter cells. The cell suicide program is triggered by specific stimuli, primarily:
- DNA damage.
- Loss of cell adhesive properties and detachment from the basement membrane (a phenomenon known as anoikis).
Regulation of this complex process is carried out by a large family of genes. The main pro-apoptotic controller is the p53 gene. Its role is to initiate apoptosis when the cell can no longer independently repair damaged DNA.
Evasion of Apoptosis in Carcinogenesis
To survive and manifest its potential for progression, a malignant tumor must disrupt cell self-destruction mechanisms. Apoptotic pathology in neoplasms develops through two main scenarios.
First, multiple mutations occur in pro-apoptotic signaling pathways, preventing the death signal from reaching the cell's executioner structures. Second, the cell loses critical regulatory molecules responsible for genomic integrity. A prime example is the loss of p53 gene function. Without this "guardian," a cell with fatal DNA damage continues to divide, passing defects to its progeny and developing pronounced atypia.
Insensitivity to Growth Inhibition and Evasion of Senescence
A fundamental process in carcinogenesis is the disruption of growth inhibition. Normally, the cell cycle is strictly controlled by a balance of two forces:
- Oncogenes — encode proteins that stimulate cell growth and division.
- Tumor suppressor genes — produce products that brake excessive proliferation.
Tumor suppressor genes form a complex network of checkpoints within the cell. Their primary goal is to prevent uncontrolled growth. Key genes in this system, such as RB and p53, continuously monitor genotoxic stress. If stress is detected, they immediately block proliferation. Interestingly, in normal, healthy tissues, oncogene expression more frequently leads to oncogene-induced senescence or cell cycle arrest rather than rampant division.
If inhibitory pathways function properly, a damaged cell has only two outcomes:
- Induction of immediate apoptosis.
- Participation in differentiation, leading to entry into the postmitotic pool (a state where the cell permanently loses its replicative potential).
Tumor cells successfully avoid both outcomes, acquiring the capacity for endless replication and, ultimately, metastasis.